4/30/19: Invicro and iThera Medical Strategic Partnership Will Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform

Tuesday, September 24, 2019

Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision Optoacoustic imaging platform in Invicro’s in vivo laboratory out of its Boston headquarters. Both companies will come together to uniquely offer Pharmaceutical, Biotech and Academia sponsors services from the optoacoustic platform that will identify and quantify disease-related biomarkers at both a molecular and anatomical level through pre-clinical full body tomographic scans.

Invicro, iThera Medical, MSOT inVision Optoacoustic Imaging Platform
Mr. Tullio Giannitti, General Manager, Americas at iThera Medical and Ms. Ciara Finucane, Senior Director and Business Leader of Discovery Research at Invicro with the MSOT inVision platform.

Invicro is a leading provider of quantitative imaging biomarkers, core lab services and software solutions for research and drug development, and Munich-based iThera Medical develops unique multispectral optoacoustic imaging technologies enabling non-invasive, real-time visualization of anatomical, functional and molecular information in living tissue at high spatial resolution. This collaboration will deliver more versatile and accurate imaging biomarkers for preclinical drug discovery research, while reducing the duration and costs of biopharmaceutical drug development.

“We are pleased to partner with iThera Medical to jointly offer enhanced pre-clinical imaging capabilities with the MSOT inVision platform,” said Ms. Ciara Finucane, MSc, Senior Director and Business Leader of Discovery Research at Invicro. “Combining iThera Medical’s technology with Invicro’s advanced quantitative imaging biomarkers offers our Pharma and Biotech sponsors a comprehensive and efficient solution to answer their research questions faster.”

“With this partnership, iThera Medical and Invicro continue to strengthen their strategy jointly to offer global pharma, biotech, and academic research communities the industry’s most premium imaging, analytics and technology solutions to support the complete drug discovery value chain,” stated Mr. Tullio Giannitti, General Manager, Americas at iThera Medical. “This collaboration is further proof of the value that MSOT imaging brings to clients in drug discovery. Invicro’s strategic imaging services align with iThera Medical’s vision, technologies and industry experience. We are pleased to have the opportunity to collaborate with the global leader in imaging biomarker services.”

4/30/19: Invicro and iThera Medical Strategic Partnership Will Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform
Medical Device News Magazinehttp://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here